APA (7th ed.) Citation

Kaulen, L. D., Karschnia, P., Doubrovinskaia, S., Abramson, J. S., Martinez-Lage, M., Shankar, G., . . . Dietrich, J. (2024). Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. American journal of hematology, 99(12), . https://doi.org/10.1002/ajh.27505

Chicago Style (17th ed.) Citation

Kaulen, Leon D., et al. "Toxicities and Outcome After CD19-directed Chimeric Antigen Receptor T-cell Therapy for Secondary Neurolymphomatosis." American Journal of Hematology 99, no. 12 (2024). https://doi.org/10.1002/ajh.27505.

MLA (9th ed.) Citation

Kaulen, Leon D., et al. "Toxicities and Outcome After CD19-directed Chimeric Antigen Receptor T-cell Therapy for Secondary Neurolymphomatosis." American Journal of Hematology, vol. 99, no. 12, 2024, https://doi.org/10.1002/ajh.27505.